# Molecular Pharmacology (USA) Ltd.

Molecular Pharmacology (USA) Ltd. is a company headquartered in Perth, Western Australia, Belgium.

## Company overview

- **Legal name:** Molecular Pharmacology (USA) Ltd.
- **Former names in filing history:** Molecular Pharmacology (USA) LTD (2005-09-26 to 2007-03-21); BLUE HAWK VENTURES INC (2003-01-23 to 2005-08-08)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Perth, Western Australia, Belgium
- **Incorporated in:** NV
- **Fiscal year end:** June 30
- **SEC CIK:** 0001191357

## About

Molecular Pharmacology (USA) Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001191357, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-09-08, it reported net income of USD -116,928 for the fiscal period ended 2014-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-06-30)

- **Net income:** -$116,928 (USD -116,928)
- **Cash and equivalents:** $2,378 (USD 2,378)
- **Operating cash flow:** -$105,410 (USD -105,410)

### FY2013 (period ended 2013-06-30)

- **Net income:** -$209,900 (USD -209,900)
- **Cash and equivalents:** $7,046 (USD 7,046)
- **Operating cash flow:** -$206,465 (USD -206,465)

### FY2012 (period ended 2012-06-30)

- **Net income:** -$179,382 (USD -179,382)
- **Cash and equivalents:** $2,572 (USD 2,572)
- **Operating cash flow:** -$178,237 (USD -178,237)

### FY2011 (period ended 2011-06-30)

- **Net income:** -$121,860 (USD -121,860)
- **Cash and equivalents:** $8,675 (USD 8,675)

## Recent SEC filings

- Form 10-Q — filed 2014-11-13 — period 2014-09-30 — MLPH FORM 10-Q 09-30-2014
- Form 10-K — filed 2014-09-08 — period 2014-06-30 — MLPH FORM 10-K - 06-30-2014
- Form 10-Q — filed 2014-05-06 — period 2014-03-31 — MLPH FORM 10Q 03-31-2014
- Form 10-Q — filed 2014-02-11 — period 2013-12-31 — MLPH FORM 10Q 12-31-2013
- Form 10-Q — filed 2013-10-31 — period 2013-09-30 — MLPH FORM 10-Q 09-30-2013
- Form 10-K — filed 2013-08-13 — period 2013-06-30 — MLPH FORM 10K 06-30-2013
- Form 8-K — filed 2013-07-19 — period 2013-07-19 — MLPH FORM 8K
- Form 10-Q — filed 2013-05-08 — period 2013-03-31 — FORM 10-Q FOR PERIOD ENDED MARCH 31, 2013
- Form 10-Q — filed 2013-02-08 — period 2012-12-31 — MLPH FORM 10 Q 2012-12-31
- Form 10-Q — filed 2012-11-08 — period 2012-09-30 — MLPH FORM 10 Q 2012-09-30
- Form 10-K — filed 2012-08-22 — period 2012-06-30 — MLPH FORM 10 K 06-30-2012
- Form 10-Q — filed 2012-04-23 — period 2012-03-31 — MLPH FORM 10 Q 2012-03-31

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/molecular-pharmacology-usa-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology